Anti-hypertensive treatment prolongs tPA door-to-treatment time: Secondary analysis of the INSTINCT trial.

Lesli E. Skolarus,Phillip A. Scott,James F. Burke,Eric E. Adelman,Shirley M. Frederiksen,Allison M. Kade,John D. Kalbfleisch,Andria L. Ford,William J. Meurer

Anti-hypertensive treatment prolongs tPA door-to-treatment time: Secondary analysis of the INSTINCT trial.

2012

Lesli E. Skolarus
Phillip A. Scott
James F. Burke
Eric E. Adelman
Shirley M. Frederiksen
Allison M. Kade
John D. Kalbfleisch
Andria L. Ford
William J. Meurer

Background/Purpose Identifying modifiable tPA treatment delays may improve stroke outcomes. We hypothesized that pre-thrombolytic anti-hypertensive treatment (AHT) may prolong door-to-treatment time (DTT).

Keywords:

Physical therapy
Diabetes mellitus
Stroke
Medicine
secondary analysis
treatment time
anti hypertensive treatment
Internal medicine
Surgery

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations